Holch JW, Ohnmacht AJ, Stintzing S, Heinrich K, et al. FOLFIRI with cetuximab or bevacizumab in RAS wild-type metastatic colorectal cancer: Refining first-line treatment selection by combining clinical parameters: A post hoc analysis of the randomized open-label phase III trial FIRE-3/AIO KRK0306. Eur J Cancer 2025;220:115388.
PMID: 40179821